Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05111717
Other study ID # MSKU 02/VII
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 17, 2021
Est. completion date December 30, 2021

Study information

Verified date March 2023
Source Mugla Sitki Koçman University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to demonstrate the molecular effect of desflurane on DNA by measuring the global DNA methylation level in patients under going lumbar spinal stenosis surgery under general anesthesia.


Description:

Forty patients scheduled for lumbar spinal surgery will include in the study. Peripheral venous blood samples will collect prior to the induction of anesthesia (T1) and after 120 minutes (T2). Anesthesia will maintaine with 40%-60% O2-air mixture and 6% desflurane. DNA will obtain from blood samples with the help of DNA isolation kit and global DNA methylation analysis will perform by ELISA method.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date December 30, 2021
Est. primary completion date December 25, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. Ability to understand and willingness to sign an informed consent form 2. Elective lumbar spinal surgery that will take at least 120 minutes, 3. American Society of Anesthesiologists (ASA) physical status I and II 4. Be between the ages of 18 and 65 Exclusion Criteria: 1. Patients with ASA physical status III or IV disease 2. Smoking or alcohol consumption 3. Chronic systemic disease (diabetes mellitus,chronic pulmonary disorders, chronic kidney and liver disorders 4. recently received radiation, chemotherapy 5. malignancy 6. blood transfusion in operation 7. use of antioxidant supplements 8. have received general anesthesia in the last three months 9. Patients with known occupational exposures (operating room personnel, chemical plant workers

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Desflurane
Peripheral venous blood samplesof patients will collected at two time points as follows: before the premedication and the induction of anesthesia (T1): 120 minutes after the beginning of anesthesia (T2). Anesthesia maintenance will be provided with 40% O2 and minimum alveolar concentration (MAC) in 60% air with 6% desflurane. DNA will be obtained from blood samples with the help of DNA isolation kit, and global DNA methylation analysis will performed by ELISA method.

Locations

Country Name City State
Turkey Mugla Sitki Kocman University Training and research Hospital Mugla

Sponsors (1)

Lead Sponsor Collaborator
Mugla Sitki Koçman University

Country where clinical trial is conducted

Turkey, 

References & Publications (3)

Bilban M, Jakopin CB, Ogrinc D. Cytogenetic tests performed on operating room personnel (the use of anaesthetic gases). Int Arch Occup Environ Health. 2005 Feb;78(1):60-4. doi: 10.1007/s00420-004-0579-1. Epub 2005 Feb 10. — View Citation

Chowdhury B, Cho IH, Irudayaraj J. Technical advances in global DNA methylation analysis in human cancers. J Biol Eng. 2017 Mar 1;11:10. doi: 10.1186/s13036-017-0052-9. eCollection 2017. — View Citation

Jaloszynski P, Kujawski M, Wasowicz M, Szulc R, Szyfter K. Genotoxicity of inhalation anesthetics halothane and isoflurane in human lymphocytes studied in vitro using the comet assay. Mutat Res. 1999 Feb 19;439(2):199-206. doi: 10.1016/s1383-5718(98)00195-8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Global DNA methylation change 5 minutes before and 120 minutes after anesthesia induction in peripheral blood mononuclear cells The global DNA methylation level will be measured 5 minutes before and 120 minutes after anesthesia induction. 5 minutes before induction of anesthesia ,120 minutes after the beginning of anesthesia
See also
  Status Clinical Trial Phase
Completed NCT01677169 - Effect of Noni Juice on Lipid Peroxidation-derived DNA Adducts in Heavy Smokers Phase 2
Recruiting NCT04372914 - Prevention of Oral DNA Damage by Black Raspberries N/A
Terminated NCT03893617 - Brief Stresses Experimental Study Phase 1
Completed NCT03319654 - Impact of DNA Fragmentation in Sperm on Pregnancy Outcome After Intra-uterine Insemination in a Spontaneous Cycle N/A
Active, not recruiting NCT06204523 - Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer
Completed NCT02696811 - The Effects of Foods on Cell Damage Study N/A
Completed NCT01461395 - Polscope Sperm: A Non-invasive Method to Assess DNA Damage in Individual Sperm N/A
Recruiting NCT04081428 - Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT
Not yet recruiting NCT05558046 - Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique
Recruiting NCT04795440 - Comparison of ICSI Outcomes in Cycles Using Testicular and Ejaculate Sperm From Couples With High SDF N/A
Completed NCT05306002 - Nutritional Intervention and DNA Damage of Patients With HBOC N/A
Completed NCT04772703 - DNA Damage in Critically Ill COVID-19 Patients
Recruiting NCT05596149 - Assessment of the Cytotoxic and Genotoxic Effect of Toothpastes With Different Forms of Fluoride on the Buccal Mucosa N/A
Recruiting NCT03908736 - Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation N/A
Completed NCT04721938 - Healthy Parents - Healthy Children. Weight Loss Before Fertility Treatment N/A
Recruiting NCT03652142 - Predictive Biomarkers for Response to Nivolumab in Head and Neck Squamous Cell Carcinoma
Completed NCT00854178 - Toxicogenomic and Immunocytotoxic Effects of Propofol and Isoflurane Anesthetics in Patients Undergoing Elective Surgery Phase 4
Active, not recruiting NCT05277961 - Quantification of DNA Repair Products in the Urine After Ultraviolet Radiation of the Skin N/A
Completed NCT02058082 - Testicular Versus Ejaculated Spermatozoa for IVF/ICSI in Men With High Sperm DNA Damage N/A
Completed NCT05007171 - Changes in Anthropometric, Biochemical and DNA Damage Parameters After 3-weeks VLCD in Severely Obese Patients N/A